632 related articles for article (PubMed ID: 16132527)
1. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
[TBL] [Abstract][Full Text] [Related]
2. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
[TBL] [Abstract][Full Text] [Related]
3. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
[TBL] [Abstract][Full Text] [Related]
4. Quantification of thrombospondin-1 secretion and expression of alphavbeta3 and alpha3beta1 integrins and syndecan-1 as cell-surface receptors for thrombospondin-1 in malignant glioma cells.
Naganuma H; Satoh E; Asahara T; Amagasaki K; Watanabe A; Satoh H; Kuroda K; Zhang L; Nukui H
J Neurooncol; 2004 Dec; 70(3):309-17. PubMed ID: 15662972
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
Winkler S; Stahl RC; Carey DJ; Bansal R
J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
[TBL] [Abstract][Full Text] [Related]
6. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
Yeaman C; Rapraeger AC
J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
[TBL] [Abstract][Full Text] [Related]
7. Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein CASK/LIN-2 during rat brain development.
Hsueh YP; Sheng M
J Neurosci; 1999 Sep; 19(17):7415-25. PubMed ID: 10460248
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones.
Birch MA; Skerry TM
Bone; 1999 Jun; 24(6):571-8. PubMed ID: 10375199
[TBL] [Abstract][Full Text] [Related]
9. Expression of the cell-surface heparan sulfate proteoglycan mRNA in monkey submandibular gland.
Yamagata E; Kamada A
J Osaka Dent Univ; 1999 Oct; 33(2):83-7. PubMed ID: 10863479
[TBL] [Abstract][Full Text] [Related]
10. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
11. Growth factors and cytokines modulate gene expression of cell-surface proteoglycans in human periodontal ligament cells.
Worapamorn W; Haase HR; Li H; Bartold PM
J Cell Physiol; 2001 Mar; 186(3):448-56. PubMed ID: 11169984
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori and toll-like receptor agonists induce syndecan-4 expression in an NF-kappaB-dependent manner.
Smith MF; Novotny J; Carl VS; Comeau LD
Glycobiology; 2006 Mar; 16(3):221-9. PubMed ID: 16319082
[TBL] [Abstract][Full Text] [Related]
14. Cell surface proteoglycan expression by human periodontal cells.
Worapamorn W; Li H; Haas HR; Pujic Z; Girjes AA; Bartold PM
Connect Tissue Res; 2000; 41(1):57-68. PubMed ID: 10826709
[TBL] [Abstract][Full Text] [Related]
15. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
[TBL] [Abstract][Full Text] [Related]
16. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
17. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.
Shafti-Keramat S; Handisurya A; Kriehuber E; Meneguzzi G; Slupetzky K; Kirnbauer R
J Virol; 2003 Dec; 77(24):13125-35. PubMed ID: 14645569
[TBL] [Abstract][Full Text] [Related]
18. Cell surface heparan sulfate proteoglycans: target and partners of the basic fibroblast growth factor in rat Sertoli cells.
Brucato S; Bocquet J; Villers C
Eur J Biochem; 2002 Jan; 269(2):502-11. PubMed ID: 11856308
[TBL] [Abstract][Full Text] [Related]
19. Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors.
Bernfield M; Sanderson RD
Philos Trans R Soc Lond B Biol Sci; 1990 Mar; 327(1239):171-86. PubMed ID: 1969657
[TBL] [Abstract][Full Text] [Related]
20. Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.
Hsueh YP; Roberts AM; Volta M; Sheng M; Roberts RG
J Neurosci; 2001 Jun; 21(11):3764-70. PubMed ID: 11356864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
